Search for: "LaBelle v. LaBelle"
Results 661 - 680
of 12,211
Sorted by Relevance
|
Sort by Date
9 Mar 2017, 10:08 am
Bowring v. [read post]
2 Jul 2013, 9:02 am
., Inc. v. [read post]
15 Sep 2015, 6:17 pm
We’re just going to point you to an interesting decision that popped up on our radar today – Rheinfrank v. [read post]
25 Mar 2013, 7:59 am
It's A 10, Inc. v. [read post]
8 Aug 2011, 6:38 am
Pernod Ricard USA, LLC v. [read post]
18 Mar 2022, 1:20 pm
Victory Global, LLC v. [read post]
3 Oct 2022, 12:25 pm
Strow v. [read post]
15 Jan 2015, 10:01 am
., v. [read post]
5 Dec 2014, 6:00 am
Gisvold v. [read post]
29 Sep 2021, 9:13 am
Barton v. [read post]
20 Mar 2017, 9:03 am
Cruz v. [read post]
24 Oct 2013, 1:15 pm
The US FDA has announced proposed changes will be forthcoming in labeling for pain relief medication: Consumers and health care professionals will soon find updated labeling for extended-release and long-acting opioid pain relievers to help ensure their safe and appropriate use. [read post]
6 Mar 2024, 12:46 pm
Montgomery v. [read post]
27 Dec 2018, 9:54 am
Painter v. [read post]
13 Apr 2010, 9:59 pm
., and Yale University ("Enzo"), are directed to various techniques for labeling and detecting nucleic acids. [read post]
26 Feb 2021, 7:22 am
– Dennis Crouch By Avery Welker Modeling v. modelling, labeled v. labelled, traveler v. traveller. [read post]
23 Mar 2023, 2:47 pm
In Solis v. [read post]
5 Aug 2014, 12:24 pm
Martin is now the second District of Arizona case to reject Ramirez and adopt the majority reasoning that preemption applies to off-label uses (the other is Scovil v. [read post]
24 Jun 2011, 7:12 am
Rumsey this week denied a summary judgment motion to dismiss a defamation suit in which the underlying alleged libelous statement involved imputing that an individual was gay.As reported in The New York Law Journal, in the case of Yonaty v. [read post]
20 Jul 2010, 11:58 am
” In addition to these suggested ingredient statements, the draft TS also asks manufacturers to consider including the following information in their nanoproduct labels: (i) whether the nano-objects are in free or unbound form; (ii) any special disposal needs; (iii) the source from which the nano-objects were derived; (iv) the intended function or purpose of the nano-objects in the product; (v) instructions for the safe opening of the nanoproduct package; and (vi) any… [read post]
